Research Interests
My research lab focuses on using single-cell sequencing techniques to study intratumoral heterogeneity in malignant brain tumors. Intratumoral heterogeneity is the idea that individual cancer cells within a patient’s tumor are different and can respond differently to treatments. I also have an active interest in developing patient-specific models of disease where we can learn how an individual patient's tumor might respond differently than another. My ultimate goal is to further advance precision medicine approaches for malignant brain tumors, and ensure that patients are getting the right treatments for their specific tumors.
Selected Grants
Licensing Immunotherapeutic Responses in GBM: Developing A Novel GPCR-Targeted Approach
ResearchSignificant Contributor · Awarded by Charlie Teo Foundation · 2024 - 2026Deep interrogation and modeling of intratumoral heterogeneity, plasticity, and tumor evolution in glioblastoma
ResearchPrincipal Investigator · Awarded by Burroughs Wellcome Fund · 2023 - 2026Translating Single Cell Analysis into Actionable Therapeutic Strategies for Glioblastoma
ResearchPrincipal Investigator · Awarded by Kuni Foundation · 2023 - 2024External Relationships
- Servier Pharmaceuticals
- Sygnomics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.